dexamethasone - CISMeF

Preferred Label : dexamethasone;

MeSH definition : An anti-inflammatory 9-fluoro-glucocorticoid.;

MeSH synonym : hexadecadrol; methylfluorprednisolone;

CISMeF synonym : dexamethasone intensol; roxane brand of dexamethasone; merz brand 2 of dexamethasone; foy brand of dexamethasone; merck brand of dexamethasone; ECR brand of dexamethasone; alcon brand of dexamethasone; merz brand 1 of dexamethasone; ICN brand of dexamethasone;

MeSH hyponym : decameth; decaject; oradexon; decaspray; millicorten; maxidex; Decaject-L.A.; dexpak; hexadrol; dexasone; Decaject L.A.;

MeSH CAS label : Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17,21-trihydroxy-16-methyl-, (11beta,16alpha)-;

MeSH Related Number : 50-02-2 (Dexamethasone);

Registry Number MeSH : 50-02-2;

Wikipedia link : https://en.wikipedia.org/wiki/Dexamethasone;

Codes EINECS : 200-003-9;

Is substance : O;

UNII : 7S5I7G3JQL;

InChIKey : UREBDLICKHMUKA-CXSFZGCWSA-N;

Details

Origin ID

D003907;

UMLS CUI

C0011777;

ATC code(s)
- dexamethasone [ATC Code]
- dexamethasone [ATC Code]
- dexamethasone [ATC Code]
- dexamethasone and antiinfectives [ATC Code]
ATC code(s)
- dexamethasone [ATC Code]
- dexamethasone [ATC Code]
- dexamethasone [ATC Code]
- dexamethasone [ATC Code]
- dexamethasone [ATC Code]
- dexamethasone [ATC Code]
- dexamethasone [ATC Code]
- dexamethasone [ATC Code]
- dexamethasone [ATC Code]
- dexamethasone [ATC Code]
- dexamethasone [ATC Code]
- dexamethasone and antibiotics [ATC Code]
- dexamethasone and antiinfectives [ATC Code]
- dexamethasone and antiinfectives [ATC Code]
- dexamethasone and antiinfectives [ATC Code]
- dexamethasone, combinations [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- Dexamethasone adverse reaction (disorder) [SNOMED CT concept]
- dexamethasone [Substance BNPC]
Currated CISMeF NLP mapping
- Dexamethasone [ICD-11 Extension code]
- Dexamethasone [LOINC component]
- Dexamethasone [ICHI extension code]
- Dexamethasone [SMS substance]
- Dexamethasone [NCIt concept]
- Dexamethasone (substance) [SNOMED CT concept]
- dexamethasone [COVID-19 Thesaurus concept]
Indexing information
- concanavalin A-induced helper factors [MeSH Supplementary Concept]
Pharmacological action(s)
- anti-inflammatory agents [MeSH Descriptor]
- antiemetics [MeSH Descriptor]
- antineoplastic agents, hormonal [MeSH Descriptor]
- glucocorticoids [MeSH Descriptor]
- peripheral nervous system agents [MeSH Descriptor]
Record concept(s)
- Decaject-L.A. [MeSH concept]
- decaject [MeSH concept]
- decameth [MeSH concept]
- decaspray [MeSH concept]
- dexamethasone [MeSH concept]
- dexasone [MeSH concept]
- dexpak [MeSH concept]
- hexadrol [MeSH concept]
- maxidex [MeSH concept]
- millicorten [MeSH concept]
- oradexon [MeSH concept]
Related MeSH Supplementary Concept(s)
- 11-dehydrodexamethasone [MeSH Supplementary Concept]
- 11-ketodexamethasone [MeSH Supplementary Concept]
- 21-((aminopropyl)thio)dexamethasone [MeSH Supplementary Concept]
- 21-((mercaptobutyl)thio)dexamethasone [MeSH Supplementary Concept]
- 21-benzyloxy-9alpha-fluoro-16alpha-methylpregna-1,4-dien-11beta,17alpha-diol-3,20-dione [MeSH Supplementary Concept]
- 4-(carboxymethylthio)dexamethasone [MeSH Supplementary Concept]
- 6-hydroxydexamethasone [MeSH Supplementary Concept]
- 6-hydroxydexamethasone 17-propionate [MeSH Supplementary Concept]
- ALL-85 protocol [MeSH Supplementary Concept]
- ALL-VI protocol [MeSH Supplementary Concept]
- BACOD protocol [MeSH Supplementary Concept]
- BACOD-VP16 protocol [MeSH Supplementary Concept]
- BBVDD protocol [MeSH Supplementary Concept]
- BFM-ALL 81 protocol [MeSH Supplementary Concept]
- BMPD protocol [MeSH Supplementary Concept]
- Berlin-Frankfurt-Muenster protocol II [MeSH Supplementary Concept]
- CAD protocol 3 [MeSH Supplementary Concept]
- CBVD protocol [MeSH Supplementary Concept]
- CEOP-IMVP-Dexa regimen [MeSH Supplementary Concept]
- CEVAD protocol [MeSH Supplementary Concept]
- CEVD protocol [MeSH Supplementary Concept]
- CHASE protocol [MeSH Supplementary Concept]
- CIOD protocol [MeSH Supplementary Concept]
- CMD protocol [MeSH Supplementary Concept]
- CMED protocol [MeSH Supplementary Concept]
- CODBLAM IV protocol [MeSH Supplementary Concept]
- CVAD protocol [MeSH Supplementary Concept]
- CVAD-V protocol [MeSH Supplementary Concept]
- Cis-VACD protocol [MeSH Supplementary Concept]
- DAI protocol [MeSH Supplementary Concept]
- DCEP protocol [MeSH Supplementary Concept]
- DCTER protocol [MeSH Supplementary Concept]
- DEMOB protocol [MeSH Supplementary Concept]
- DFCI 91-01 protocol [MeSH Supplementary Concept]
- DFCI 95-01 protocol [MeSH Supplementary Concept]
- DHACT protocol [MeSH Supplementary Concept]
- DHAOx protocol [MeSH Supplementary Concept]
- DHAP protocol [MeSH Supplementary Concept]
- DICE protocol [MeSH Supplementary Concept]
- DIZE protocol [MeSH Supplementary Concept]
- DT PACE regimen [MeSH Supplementary Concept]
- DT-PACE protocol [MeSH Supplementary Concept]
- Dexa-BEAM protocol [MeSH Supplementary Concept]
- Dexa-PAMB protocol [MeSH Supplementary Concept]
- EDAP regimen [MeSH Supplementary Concept]
- ESHAP regimen, modified [MeSH Supplementary Concept]
- EVDAC regimen [MeSH Supplementary Concept]
- FLUDAP protocol [MeSH Supplementary Concept]
- FND protocol [MeSH Supplementary Concept]
- G-IDEA protocol [MeSH Supplementary Concept]
- GDP protocol [MeSH Supplementary Concept]
- HCVAD protocol [MeSH Supplementary Concept]
- HEAVD protocol [MeSH Supplementary Concept]
- HR-1 protocol [MeSH Supplementary Concept]
- HR-2 protocol [MeSH Supplementary Concept]
- HR-3 protocol [MeSH Supplementary Concept]
- ICE protocol 2 [MeSH Supplementary Concept]
- LBCMVD-56 protocol [MeSH Supplementary Concept]
- M-BACOD protocol [MeSH Supplementary Concept]
- M-BNCOD protocol [MeSH Supplementary Concept]
- MAD protocol [MeSH Supplementary Concept]
- MCHOD protocol [MeSH Supplementary Concept]
- MDT protocol [MeSH Supplementary Concept]
- MEV-AD protocol [MeSH Supplementary Concept]
- MLL-93 protocol [MeSH Supplementary Concept]
- MOD protocol [MeSH Supplementary Concept]
- MV26PD protocol [MeSH Supplementary Concept]
- N-(dexamethasone 21-S-ethyl-2'-amino)tetramethylrhodamine [MeSH Supplementary Concept]
- NCX1021 [MeSH Supplementary Concept]
- ND8008 [MeSH Supplementary Concept]
- PD protocol [MeSH Supplementary Concept]
- PETHEMA ALL-3-97 protocol [MeSH Supplementary Concept]
- ROAD-IN protocol [MeSH Supplementary Concept]
- TCID protocol [MeSH Supplementary Concept]
- TVTG protocol [MeSH Supplementary Concept]
- VAD I protocol [MeSH Supplementary Concept]
- VAD protocol [MeSH Supplementary Concept]
- VAD regimen [MeSH Supplementary Concept]
- VBAD protocol [MeSH Supplementary Concept]
- VBAMDex protocol [MeSH Supplementary Concept]
- VCAD regimen [MeSH Supplementary Concept]
- VCD protocol [MeSH Supplementary Concept]
- VID protocol [MeSH Supplementary Concept]
- VIM-D protocol [MeSH Supplementary Concept]
- VMD protocol [MeSH Supplementary Concept]
- aminopyrine, dexamethasone, phenylbutazone, thiamine, vitamin B12 drug combination [MeSH Supplementary Concept]
- ascorbic acid, cysteamine, dexamethasone drug combination [MeSH Supplementary Concept]
- auricularum [MeSH Supplementary Concept]
- azidoamphenicol, clotrimazole, dexamethasone drug combination [MeSH Supplementary Concept]
- chloramphenicol, dexamethasone, neomycin drug combination [MeSH Supplementary Concept]
- chlorpromazine, dexamethasone, metoclopramide, orphenadrine drug combination [MeSH Supplementary Concept]
- clemastine, dexamethasone drug combination [MeSH Supplementary Concept]
- corticosteroid methanetriol mixture [MeSH Supplementary Concept]
- dexamethasone 17-propionate [MeSH Supplementary Concept]
- dexamethasone 17-valerate [MeSH Supplementary Concept]
- dexamethasone 21-(beta-isothiocyanatoethyl)thioether [MeSH Supplementary Concept]
- dexamethasone 21-bromoacetate [MeSH Supplementary Concept]
- dexamethasone 21-glucoside [MeSH Supplementary Concept]
- dexamethasone 21-iodoacetate [MeSH Supplementary Concept]
- dexamethasone 21-methanesulfonate [MeSH Supplementary Concept]
- dexamethasone 21-palmitate [MeSH Supplementary Concept]
- dexamethasone 21-phenylpropionate [MeSH Supplementary Concept]
- dexamethasone 21-phosphate [MeSH Supplementary Concept]
- dexamethasone 21-tributylacetate [MeSH Supplementary Concept]
- dexamethasone acetate [MeSH Supplementary Concept]
- dexamethasone dipropionate [MeSH Supplementary Concept]
- dexamethasone glucuronide [MeSH Supplementary Concept]
- dexamethasone linoleate [MeSH Supplementary Concept]
- dexamethasone oxetanone [MeSH Supplementary Concept]
- dexamethasone succinate dextran [MeSH Supplementary Concept]
- dexamethasone sulfate ester [MeSH Supplementary Concept]
- dexamethasone trimethyl acetate [MeSH Supplementary Concept]
- dexamethasone trioxa undecanoate [MeSH Supplementary Concept]
- dexamethasone, dimethyllauryl benzylammonium, parachlorophenol, thymol drug combination [MeSH Supplementary Concept]
- dexamethasone, neomycin, polymyxin B drug combination [MeSH Supplementary Concept]
- dexamethasone-(C21-phosphoramide)-(anti-EGFR) [MeSH Supplementary Concept]
- dexamethasone-17-carboxamide [MeSH Supplementary Concept]
- dexamethasone-21-sulfobenzoate [MeSH Supplementary Concept]
- dexamethasone-FK506 heterodimer [MeSH Supplementary Concept]
- dexamethasone-beta-cyclodextrin [MeSH Supplementary Concept]
- dexamethasone-bis-peptide nucleic acid [MeSH Supplementary Concept]
- doxiproct plus [MeSH Supplementary Concept]
- exosterol [MeSH Supplementary Concept]
- hyperCDT protocol [MeSH Supplementary Concept]
- m-ACOD protocol [MeSH Supplementary Concept]
- m-BECOD protocol [MeSH Supplementary Concept]
- m-M-BACOD protocol [MeSH Supplementary Concept]
- metoclophen [MeSH Supplementary Concept]
- neomycin sulfate, pyridine carboxylate of dexamethasone, tyzanol drug combination [MeSH Supplementary Concept]
- otomize [MeSH Supplementary Concept]
- percutalgine [MeSH Supplementary Concept]
- sofradex [MeSH Supplementary Concept]
- supertendin [MeSH Supplementary Concept]
- tresaderm [MeSH Supplementary Concept]
- ultra-demoplas [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Dexamethasone [ICD-11 Extension code]
- Dexamethasone [LOINC Challenge]
- Dexamethasone [NCIt concept]
- Dexamethasone [LOINC component]
- Dexamethasone (substance) [SNOMED CT concept]
- Product containing dexamethasone (medicinal product) [SNOMED CT concept]
- dexamethasone [ATC Code]
- dexamethasone [ATC Code]
- dexamethasone [ATC Code]
- dexamethasone [ATC Code]
- dexamethasone [ATC Code]
- dexamethasone [ATC Code]
- dexamethasone [ATC Code]
- dexamethasone [ATC Code]
- dexamethasone [ATC Code]
- dexamethasone [ATC Code]
- dexamethasone [ATC Code]
- dexamethasone [Substance BNPC]
- dexamethasone preparation [SNOMED Notion]
Validated automatic mappings to BTNT
- dexamethasone [ATC Code]
- dexamethasone [ATC Code]
- dexamethasone [ATC Code]
- dexamethasone [ATC Code]
- dexamethasone [ATC Code]
- dexamethasone [ATC Code]
- dexamethasone [ATC Code]
- dexamethasone [ATC Code]
- dexamethasone [ATC Code]
- dexamethasone [ATC Code]
- dexamethasone [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients